Cite
HARVARD Citation
Herishanu, Y. et al. (n.d.). Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. American journal of hematology. 95 (6), pp. 604-611. [Online].